June rush drives near-record quarter for biotech flotations
Biotech IPOs raised a huge $2.3bn on Western exchanges in the second-quarter of 2018, as private companies rushed to market ahead of the summer lull.
Kickstarting ideas
Independent, data-driven daily news and analysis on pharma, biotech and medtech.